Discover

MSLE
Satellos Bioscience Inc.
6.70
1 x 10.20
1 x 10.15
bid
ask
-
0.12
1.69%
1 @ 04:00 PM
6.82 +0.12 (1.79%)
Ytd13.95%
1y3.08%
6.43
day range
6.93
5.30
52 week range
13.39
Open6.67Prev Close6.82Low6.43High6.93Mkt Cap142.15M
Vol30.78KAvg Vol42.12KEPS-1.95P/EN/AForward P/EN/A
BetaN/AShort RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1250-d Avg8.35200-d Avg8.491yr Est0.00
Income Statement
Operating Expenses12.17M
Research and Development Expense9.64M
Selling, General and Administrative Expense2.53M
Operating Income-12.16M
Income Tax Expense44.00K
Net Income-11.72M
Net Income Common Stock-11.72M
Net Income Common Stock (USD)-11.72M
Consolidated Income-11.72M
Earnings per Basic Share-0.56
Earnings per Basic Share (USD)-0.56
Earnings per Diluted Share-0.56
Earning Before Interest & Taxes (EBIT)-11.67M
Earning Before Interest & Taxes (USD)-11.67M
Weighted Average Shares20.83M
Weighted Average Shares Diluted20.83M
Balance Sheet
Cash and Equivalents7.39M
Cash and Equivalents (USD)7.39M
Investments54.45M
Investments Current54.45M
Current Assets65.76M
Property, Plant & Equipment Net7.00K
Total Assets65.77M
Current Liabilities5.86M
Total Liabilities5.86M
Accumulated Retained Earnings (Deficit)-103.46M
Accumulated Other Comprehensive Income-1.70M
Shareholders Equity59.91M
Shareholders Equity (USD)59.91M
Assets Non-Current7.00K
Trade and Non-Trade Payables5.86M
Cash Flow
Depreciation, Amortization & Accretion1000
Net Cash Flow from Financing37.00K
Net Cash Flow / Change in Cash & Cash Equivalents-11.30M
Issuance (Purchase) of Equity Shares37.00K
Net Cash Flow from Investing-3.34M
Net Cash Flow - Investment Acquisitions and Disposals-3.34M
Net Cash Flow from Operations-8.03M
Effect of Exchange Rate Changes on Cash 27.00K
Share Based Compensation922.00K